A comparative study on the treatment effect of Hytrin alone or Hytrin/Hinechol combined administration to patients with prostatic hyperplasia with lower urinary tract symptoms (LUTS)

Cheongju ST.Mary's Hospital0 个研究点目标入组 200 人开始时间: 待定最近更新: 2021年1月6日

试验速览

暂无简介。

•1) Men over 40 years old
•2) Those with a total score of 8 or more in the International Prostate Symptom Score (IPSS)
•3) Those who voluntarily decide to participate in this study and consent in writing to the subject's consent

•1) Those with hypersensitivity to Hythrin-based drugs (alpha-blocker) and Heinecol-based drugs (cholinergic drugs)
•2) Those with clinically significant circulatory diseases (myocardial infarction, heart failure, angina, deep veins, pacemaker use, orthostatic hypotension, uncontrolled hypotension)
•3) Those on hemodialysis
•4) Those who show persistent oliguria due to renal function abnormalities
•5) Patients with moderate hepatic impairment (Child-Pugh grade B)
•6) Those who participated in other interventional clinical trials within 6 months of screening
•7) Those who have a history of or present malignant tumors, and who are inadequate to participate in the study as judged by the principal investigator or the investigator.
•8) Asthma patients, patients with hyperthyroidism
•9) Others who are inadequate to participate in the research as judged by theprincipal investigator or the investigator.

发起方

Cheongju ST.Mary's Hospital